Zimmer Biomet rises after quarterly results beat estimates
View all comments(0)
Shares of medical device maker Zimmer Biomet Holdings ZBH.N rise 1.5% to $103.87 premarket
ZBH posts Q1 adj. profit of $1.81 per share, beating analysts' estimate of $1.77 per share, according to data compiled by LSEG
Company reports Q1 revenue of $1.91 billion vs estimates of $1.90 billion
Company cuts its annual adj profit forecast to a range of $7.9 and $8.1 per share, compared with previously projected adj profit forecast of $8.15 to $8.35 per share
However, ZBH expects 2025 revenue growth to be 5.7% to 8.2% including co's acquisition of orthopedic surgical devices maker Paragon 28 7GQ.F, currency and current tariff impact
As of last close, ZBH has fallen 3.1% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide

Is Micron the Next Nvidia? Why the 2026 "Memory Crunch" Makes MU Stock a Top AI Buy

U.S. April CPI Preview: Fed May Abandon Rate Cuts Until 2026?

Copper Prices Near All-Time Highs. Citi: If Strait of Hormuz Is Unblocked, Price Will Rise to $15,000 by Year-End

Tradingkey







Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.